Журнал дерматита

Абстрактный

Intralesional Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

Georgina Heddle

A 21 year old Pakistani male was referred to dermatology at a tertiary centre for management of cutaneous leishmaniasis. The clinical diagnosis of cutaneous leishmaniasis was confirmed by histopathology and tissue culture. There is evolving literature suggesting intralesional meglumine antimoniate is a highly efficacious and safe treatment of cutaneous leishmaniasis. We present a case of Old World cutaneous leishmaniasis which resolved with intralesional meglumine antimoniate treatment. The case highlights the potential benefits of meglumine antimoniate in the treatment of cutaneous leishmaniasis and need for prospective studies to establish the safety and efficacy of the treatment.